- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2018-003190-96.
Displaying page 1 of 1.
EudraCT Number: 2018-003190-96 | Sponsor Protocol Number: SHR-3680-III-HSPC | Start Date*: 2020-02-10 | ||||||||||||||||
Sponsor Name:Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ||||||||||||||||||
Full Title: One multicenter, randomized, open, phase III clinical study on SHR3680 combined with androgen deprived therapy (ADT) versus Bicalutamide combined with ADT in treatment of metastatic hormone-sensiti... | ||||||||||||||||||
Medical condition: Metastatic hormone-sensitive prostate cancer with high tumor load | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: CZ (Ongoing) BG (Ongoing) PL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.